Company profile: Navidea Biopharmaceuticals
1.1 - Company Overview
Company description
- Provider of precision immunodiagnostic agents and immunotherapeutics for cancer, autoimmune, and infectious diseases, leveraging the Manocept CD206-targeting platform. Offerings include Tc99m/99mTc-tilmanocept diagnostics for rheumatoid arthritis, Kaposi sarcoma, cardiovascular plaque (particularly in HIV subjects), and sentinel lymph node biopsy in cervical cancer, plus CD206-targeted therapy for Kaposi sarcoma.
Products and services
- Manocept™ CD206-Targeting Platform: Engineers a receptor-specific system that binds the CD206 mannose receptor on macrophages to enable diagnosis and treatment across cancer and autoimmune indications
- Tc99m Tilmanocept for Rheumatoid Arthritis: Deploys a 99mTc-labeled agent that targets macrophages to diagnose rheumatoid arthritis, enabling earlier and more accurate detection to improve patient outcomes
- 99mTc-tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer: Delivers a radiopharmaceutical-grade diagnostic agent employed during cervical cancer surgeries for the sentinel lymph node biopsy procedure using 99mTc labeling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Navidea Biopharmaceuticals
Alcor Scientific
HQ: United States
Website
- Description: Provider of diagnostic instrumentation and medical devices, including iSED ELITE and iSED fully automated ESR analyzers delivering results in 20 seconds and miniiSED compact ESR analyzer for low-volume labs; SEDiTROL bi-level human-based whole blood controls; MIZAR rheometer measuring red blood cell deformability, elasticity, and aggregability; and SENTINELplus enteral feeding pump with drop-detection and advanced memory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alcor Scientific company profile →
HealthFair
HQ: United States
Website
- Description: Provider of health and wellness services including awareness, education and preventive health tests via mobile health centers to help consumers improve and extend lives through early detection and prevention of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthFair company profile →
Millennium Health
HQ: United States
Website
- Description: Provider of accredited specialty laboratory services delivering drug testing and integrated intelligence, including Millennium UDT urine drug tests with quantitative results, Millennium OFT oral fluid testing, Continuum telemedicine-compatible oral fluid collection kits, the Signals Report analyzing drug test results for trends, RADAR Hotline consultations with toxicologists and clinical pharmacists, and Intellium for clinical education and navigating payer policies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millennium Health company profile →
Medix Biochemica
HQ: Finland
Website
- Description: Provider of critical raw materials to the in vitro diagnostics (IVD) industry; a global, market-leading supplier enabling IVD customers to deliver accurate results to billions of patients worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medix Biochemica company profile →
Revenio Group
HQ: Finland
Website
- Description: Provider of ophthalmological devices and solutions, offering iCare intraocular pressure measurement devices (IC100 handheld; IC200 for multiple patient positions), TONOVET for veterinarians, HOME2 for home IOP monitoring with app data sharing, and fundus imaging systems including EIDON AF (true-color confocal, fully automated) and DRSplus (high-quality images from small pupils and through cataracts/media opacities).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Revenio Group company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Navidea Biopharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Navidea Biopharmaceuticals
2.2 - Growth funds investing in similar companies to Navidea Biopharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Navidea Biopharmaceuticals
4.2 - Public trading comparable groups for Navidea Biopharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →